Paul Howe, chief commercial officer at Protega Pharma, discusses how regulatory agencies are updating their policies based on the presence of abuse-deterrent medications. Pharmaceutical Executive: How ...

A new tool from the state of Ohio aims to help officials proactively address heightened drug overdose risk in local ...

The genetic polymorphisms that may affect individual responses to cardiovascular agents are reviewed, and the application of pharmacogenetics to cardiovascular disease management is discussed.

"Our ability to directly study drug responses at single-cell levels in primary tumor samples from patients in a multiplexed ...

Six grade 5 (fatal) AEs were attributed to a study drug. Among patients treated with the phase II dose combination, objective responses occurred in 35 of 44 (80%). Median time to response was 1.4 ...

More about cancer biomarker for predicting response to drugs targeting mitotic checkpoint kinases and cell division Genomic instability – an increased tendency for DNA mutations and both structural ...

Two overarching goals tied to a futuristic vision of personalized medicine are to maximize individually derived benefits from available therapeutic drugs or biological agents and identify a ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Illinois lawmakers express their support of the Prescription Drug Affordability Act in response to former President Biden’s ...

The UN Development Programme (UNDP) has delivered 3000 antiretroviral drugs to Fiji to support the HIV response. The UNDP ...